Antisocial personality disorder (ASPD) is diagnosed more frequently in men than in women, with prevalence rates estimated at approximately 3% for men compared to 1% for women in the general population. This disorder is characterized by a pervasive pattern of disregard for and violation of the rights of others, often accompanied by a lack of empathy and remorse.

Negative symptoms in schizophrenia represent a deficit or loss of normal functioning, such as avolition or psychomotor retardation. Reduced voluntary motion, or catatonic-like behavior, reflects this lack of initiative. Conversely, hallucinations (perceiving things not there) and delusions (false beliefs) are classified as positive symptoms, which represent an excess or distortion of normal psychological processes.

Depression is a complex, multifactorial disorder. It is widely accepted in clinical psychology that depression arises from a biopsychosocial model. This includes genetic predispositions (biological), individual life experiences and personality traits (personal), and environmental or societal stressors (socio-cultural). Therefore, all these levels interact to influence an individual's susceptibility to and manifestation of depressive symptoms.

Antipsychotic medications are primarily indicated for the treatment of schizophrenia and other psychotic disorders. They work by modulating neurotransmitter activity, particularly dopamine, to reduce symptoms such as hallucinations and delusions. While they are sometimes used off-label for other conditions, their primary clinical application is the management of psychosis.

Catatonic schizophrenia is a subtype characterized primarily by marked psychomotor disturbances. Patients may exhibit extreme immobility, rigidity, or peculiar voluntary movements. Jill's symptoms of prolonged immobility and increased muscle tone are hallmark signs of the catatonic state, which distinguishes this subtype from others like paranoid or hebephrenic schizophrenia, which are defined by different primary symptom clusters.

Bipolar disorder is a chronic mood disorder defined by distinct periods of extreme mood elevation, known as mania or hypomania, alternating with periods of deep depression. Managing this condition typically requires a comprehensive treatment plan involving mood-stabilizing medications and psychotherapy to help patients maintain emotional stability and improve their overall quality of life.

Tardive dyskinesia is a serious and potentially permanent side effect associated with long-term use of typical antipsychotics like Thorazine. It is characterized by repetitive, involuntary movements, most commonly involving the tongue, lips, and facial muscles. Patients prescribed these medications are typically monitored closely for the emergence of these specific motor symptoms.

Dysthymia, now clinically referred to as Persistent Depressive Disorder, is characterized by a chronic, low-level depressed mood that lasts for at least two years. Unlike major depressive episodes, which are acute, dysthymia is long-lasting. A significant clinical risk is 'double depression,' where an individual with chronic dysthymia experiences a superimposed episode of major depression, leading to a more severe and complex clinical presentation.

Bipolar disorder is a mood disorder characterized by significant fluctuations in energy and mood. These cycles include manic episodes, marked by elevated mood and high energy, and depressive episodes, marked by low mood and lethargy. The hallmark of the disorder is this cyclical transition between these two extreme states.

Comorbidity, also known as dual diagnosis or co-occurring disorders, describes the presence of two or more psychiatric conditions in the same person at the same time. This is a significant factor in clinical practice, as the interaction between multiple disorders can complicate treatment plans and affect the overall prognosis for the patient.